Induced Abortion After Previous Caesarean Section: A Scoping Review
- PMID: 40219613
- DOI: 10.1111/ajo.70013
Induced Abortion After Previous Caesarean Section: A Scoping Review
Abstract
Background: Previous caesarean section (CS) is increasingly common among women undergoing induced abortion.
Aims: To map and analyse existing literature on abortion safety, outcomes and management in those with previous CS.
Materials and methods: Four databases were systematically searched from inception to July 2024. Primary human studies in English reporting on outcomes, safety or management of first- or second-trimester medical (MToP) or surgical (SToP) abortion in women with previous CS were included. Uterine rupture incidence was analysed cumulatively in the first and secondtrimesters by the number of CS and the type of prostaglandin used. Data on the efficacy and safety of MToP and SToP, including studies reporting on the management of abortion in the setting of abnormal placentation, were collected and analysed by theme.
Results: In total, 164 articles met inclusion criteria. Incidence of uterine rupture in first-trimester MToP was 0 of 2194 cases, in second-trimester misoprostol MToP in those with 1 previous CS was 0.5% (10/1910) and 2.2% (18/835) in women with ≥ 2 CS (p < 0.001). Mifepristone priming did not increase the rupture rate in second-trimester MToP (p = 0.77). Previous CS was a modest risk factor for retained products after MToP across both trimesters (OR 1.48, CI 1.29-1.70).
Conclusion: Medical and surgical abortion in the first and second trimester appears safe in women with prior CS; however, risks include uterine rupture, need for surgical intervention and haemorrhage from undiagnosed placenta accreta. Further research and guidance are needed on managing abortion after previous classical CS, ≥ 3 previous CS and those with abnormally invasive placenta.
Keywords: abortion; accreta; caesarean section; review; termination of pregnancy.
© 2025 The Author(s). Australian and New Zealand Journal of Obstetrics and Gynaecology published by John Wiley & Sons Australia, Ltd on behalf of Royal Australian and New Zealand College of Obstetricians and Gynaecologists.
Similar articles
-
Mifepristone priming and subsequent misoprostol for second trimester medical abortion in women with previous caesarean delivery.Aust N Z J Obstet Gynaecol. 2023 Jun;63(3):301-307. doi: 10.1111/ajo.13653. Epub 2023 Feb 15. Aust N Z J Obstet Gynaecol. 2023. PMID: 36789734
-
Efficacy of mifepristone - Prostaglandin analogue combination in medical termination of pregnancy up to and beyond 7 weeks of amenorrhea: The RYMMa study.Eur J Obstet Gynecol Reprod Biol. 2020 Nov;254:95-101. doi: 10.1016/j.ejogrb.2020.09.004. Epub 2020 Sep 8. Eur J Obstet Gynecol Reprod Biol. 2020. PMID: 32947143
-
Paracervical block as pain treatment during second-trimester medical termination of pregnancy: an RCT with bupivacaine versus sodium chloride.Hum Reprod. 2016 Jan;31(1):67-74. doi: 10.1093/humrep/dev286. Epub 2015 Nov 15. Hum Reprod. 2016. PMID: 26573530 Clinical Trial.
-
Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management.Reprod Health Matters. 2008 May;16(31 Suppl):162-72. doi: 10.1016/S0968-8080(08)31371-8. Reprod Health Matters. 2008. PMID: 18772097 Review.
-
Prior Cesarean Birth and Risk of Uterine Rupture in Second-Trimester Medication Abortions Using Mifepristone and Misoprostol: A Systematic Review and Meta-analysis.Obstet Gynecol. 2023 Dec 1;142(6):1357-1364. doi: 10.1097/AOG.0000000000005259. Epub 2023 Oct 26. Obstet Gynecol. 2023. PMID: 37884011
References
-
- A. P. Betran, J. Ye, A.‐B. Moller, J. P. Souza, and J. Zhang, “Trends and Projections of Caesarean Section Rates: Global and Regional Estimates,” BMJ Global Health 6, no. 6 (2021): e005671.
-
- Australian Institute of Health and Welfare, “Australia's Mothers and Babies,” 2022.
-
- Health AIo, Welfare, National Core Maternity Indicators (AIHW, 2023).
-
- A. Chan and L. C. Sage, “Estimating Australia's Abortion Rates 1985‐2003,” Medical Journal of Australia 182, no. 9 (2005): 447–452.
-
- T. Eshkoli, A. Y. Weintraub, R. Sergienko, and E. Sheiner, “Placenta Accreta: Risk Factors, Perinatal Outcomes, and Consequences for Subsequent Births,” Obstetric Anesthesia Digest 34, no. 1 (2014): 19–20.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous